LEVI GARRAWAY
Blow to Roche's cancer immunotherapy prospects as 2nd trial failsIn a study, a combination of tiragolumab and Roche's established Tecentriq drug did not slow disease progression in newly diagnosed cases o...
Japan becomes first country to approve Ronapreve Covid treatmentThe approval was based on phase 3 trials finding that the antibody cocktail dramatically reduced the likelihood that mild or moderate Covid...
US approves Roche drug for emergency use against severe Covid-19Though rising vaccinations in places such as Europe and the United States are reducing hospitalizations for COVID-19, Actemra is still bein...
Roche reports promising results from anti-Covid cocktailThe results of the Phase 3 trial showed that the combination of the antibodies casirivimab and imdevimab "reduced hospitalisation or death ...
Tocilizumab fails to improve condition of severe Covid-19 patientsThe result of the COVACTA study dashes the hopes of experts who were looking to use the rheumatoid arthritis drug as treatment option for C...
Load More